Urwana no kugabanya ibiro kandi ushakisha igisubizo cyiza? Tirzepatid irashobora kuba igisubizo washakaga.
Tirzepatid ni FDA yemewe, rimwe mu cyumweru imiti yatewe inshinge igamije gufasha kugabanya ibiro no gucunga ibiro. Cyakora mugukemura ibintu byingenzi bigira uruhare mu kongera ibiro, nko kurya, guhaga, no gusiba gastric.
Muri iki kiganiro, tuzaganira ku buryo tirzepatide ifasha mu kugabanya ibiro nicyo ushobora kwitega kuri ubu buvuzi bushya.
Tirzepatid niyambere-mubyiciro bibiri byakira reseptor agonist yibasira GLP-1 (glucagon-isa na peptide-1) na GIP (glucose-iterwa na insulineotropique polypeptide). Iyi misemburo ibiri ikomoka mu nda isanzwe irekurwa nyuma yo kurya, aho ifasha kugenzura isukari mu maraso, inzara, no kuzura. Mu kwigana ibyo bimenyetso bisanzwe, tirzepatide igabanya ubushake bwo kurya, ikongera guhaga, kandi igatinda igogorwa, igatera ibidukikije byiza byimbere kugirango igabanye ibiro bihamye kandi birambye.
Igituma tirzepatide idasanzwe nuburyo bubiri bwibikorwa. GLP-1 imaze igihe kinini izwiho kugabanya ubushake bwo kurya no kunoza igenzura rya glucose. GIP, iyo imaze gusuzumwa, ubu yerekanwe kugirango yongere insuline kandi yongere imbaraga zuzuye za GLP-1. Iyo bihujwe, izi nzira zombi zitera imbaraga zo guhuza imbaraga - kugabanya ubushake bwo kurya, kunoza imitekerereze ya metabolike, hamwe nubushobozi bwo gutwika amavuta kuruta imiti imwe. Ibi birasobanura impamvu tirzepatide irusha ubuvuzi bwa GLP-1 gusa.
Tirzepatid ifasha abantu kumva vuba vuba no kuguma igihe kirekire. Ikora ku bigo bigenzura ubushake bwo mu bwonko, bigabanya ibimenyetso byinzara kandi bigabanya irari umunsi wose. Ibi byorohereza abantu kugiti cyabo kugabanya kugaburira karori batiriwe bumva ko babuze. Igihe kirenze, uku kugabanuka kwa karori ya buri munsi biganisha ku kugabanya ibiro bifatika.
Mugutinda umuvuduko ibiryo biva mu gifu, tirzepatide yongerera ibyuzuye nyuma yo kurya. Uku gutinda kwa gastrici bifasha kugabanya guswera, guhagarika isukari yamaraso nyuma yo kurya, kandi bigashyigikira kugenzura ibice. Igisubizo nuburyo bworoshye, bugenzurwa cyane nigifu gihuza ningeso nziza yo kurya no kugabanya ibiro birebire.
Ubushobozi bwa Tirzepatid bwo gukora GLP-1 na GIP yakira itanga ibyiza byinshi byo guhinduranya. GLP-1 ifasha kugenzura isukari mu maraso, kugabanya umuvuduko, no kugabanya ubushake bwo kurya. GIP yongerera imbaraga insuline kandi ishyigikira metabolism. Hamwe na hamwe, izi nzira zitera ihinduka rikomeye ritera gutakaza amavuta kuruta gutakaza imitsi-bigatuma tirzepatide ihitamo uburyo bwo kugabanya ibiro bigenzurwa nubuvuzi.
Abantu benshi bafite umubyibuho ukabije barwana na insuline. Tirzepatide itezimbere insuline itaziguye, ituma umubiri ukoresha glucose neza. Ibi ntibigabanya gusa isukari mu maraso ahubwo binagabanya ububiko bwamavuta kandi bigabanya imbaraga za metabolike zijyanye numubyibuho ukabije. Ku bantu bafite umubyibuho ukabije na diyabete yo mu bwoko bwa 2, tirzepatide itanga inyungu ebyiri: kugabanya ibiro cyane mubuvuzi no kuzamura ubuzima bwa metabolike.
Tirzepatid yemerewe na FDA kugabanya ibiro kubantu bakuru bafite BMI ya 30 cyangwa irenga, cyangwa abafite BMI ya 27 cyangwa irenga bafite ubuzima bujyanye nubuzima nka hypertension, diabete, cyangwa gusinzira bikabije (OSA). Imbonerahamwe ikurikira irerekana muri make imikoreshereze yemewe:
Imiterere |
Icyifuzo cya BMI |
Ibindi bisabwa |
Umubyibuho ukabije |
BMI ≥ 30 |
Nta bindi bisabwa bisabwa |
Umubyibuho ukabije hamwe nubuzima |
BMI ≥ 27 |
Imiterere nka hypertension, diyabete |
OSA ikabije mubantu bakuze bafite umubyibuho ukabije |
BMI ≥ 30 |
Tirzepatid ntabwo ifasha gusa kugabanya ibiro ahubwo ifasha no kuzamura ubuzima bwiza nka OSA, ikunze kwiyongera numubyibuho ukabije. Mugabanye ibiro, abarwayi barashobora kugira ireme ryibitotsi nubuzima muri rusange.
Tirzepatid ntabwo ibereye abantu barwaye diyabete yo mu bwoko bwa 1 cyangwa amateka ya pancreatite. Irabujijwe kandi kubantu bafite amateka yumuntu ku giti cye cyangwa mumiryango ya medullary tiroyide ya kanseri (MTC) cyangwa Multiple Endocrine Neoplasia ubwoko bwa 2 (ABAGABO 2).
Ibipimo byo guhezwa |
Impamvu |
Ubwoko bwa 1 Diyabete |
Ntabwo byemewe gukoreshwa muri diyabete yo mu bwoko bwa 1 |
Amateka ya Pancreatitis |
Ibyago bya pancreatite birashobora kwiyongera |
MTC cyangwa ABAGABO 2 |
Kongera ibyago byo kubyimba tiroyide |
Tirzepatid yerekanye ibisubizo bitangaje mubigeragezo byamavuriro. Igeragezwa rya SURMOUNT-1 ryerekanye ko abarwayi bakoresha tirzepatide (15 mg) mu byumweru 72 batakaje ikigereranyo cya 22.5% by'uburemere bw'umubiri wabo wa mbere. Hano haribisubizo bishingiye kubipimo bitandukanye:
Igipimo cya Zepbound |
Gutakaza ibiro mu byumweru 72 |
Avg. Gutakaza ibiro (ibiro) |
Avg. Gutakaza ibiro (kg) |
5 mg / icyumweru |
16% |
Ibiro 35.5 |
16.1 kg |
10 mg / icyumweru |
21.4% |
Ibiro 48.9 |
22 kg |
15 mg / icyumweru |
22.5% |
Ibiro 52 |
23,6 kg |
Umwanya |
2.4% |
Ibiro 5.3 |
2.4 kg |
Mugihe tirzepatide itanga ibiro byinshi mumezi make yambere, ibizamini byamavuriro byagaragaje ko guhagarika imiti bishobora gutuma ibiro byongera. Ibi birerekana ko gukomeza gukoresha ari ngombwa kugirango tubone ibisubizo birebire.
Mu igeragezwa rya SURMOUNT-5, tirzepatide yasanze ikora 47% kurusha semaglutide yo kugabanya ibiro. Tirzepatid yatumye impuzandengo y'ibiro 50.3 igabanuka, ugereranije n'ibiro 33.1 hamwe na semaglutide. Byongeye kandi, tirzepatide yatumye igabanuka ryinshi ryubunini bwikibuno kandi rifite impuzandengo yo hejuru yo kugabanya ibiro.
Tirzepatid itangwa hakoreshejwe inshinge zidasanzwe munsi yicyumweru. Irashobora guterwa igihe icyo aricyo cyose cyumunsi, hamwe nibiryo. Ahantu ho gutera inshinge harimo ikibero, inda, cyangwa ukuboko hejuru. Kuzenguruka aho batewe inshinge na buri dose birasabwa kwirinda kurakara.
Agace k'inshinge |
Imyitozo myiza |
Ikibero |
Kuzenguruka kugirango wirinde gutera inshinge |
Inda |
Kuzenguruka buri gihe kugirango ugabanye uburakari |
Ukuboko hejuru |
Icyifuzo cyo kwiyobora |
Gahunda isanzwe yo kunywa itangirana na mg 2,5 buri cyumweru, igenda yiyongera kugeza kuri mg 5, mg 10, cyangwa mg 15 zishingiye ku kwihanganira umuntu ku giti cye. Igipimo cyiyongera buri byumweru bine kugirango ugabanye ingaruka mbi nko kugira isesemi.
Ingaruka zisanzwe zirimo isesemi, kuruka, no gucibwamo. Ibi bikunze kugaragara mubyumweru byambere byo kuvura ariko akenshi bigenda bitera imbere uko umubiri uhinduka. Kugira ngo izo ngaruka zigabanuke, abarwayi bashishikarizwa kurya ibiryo bito, kenshi kandi bakagumana amazi.
Kugira ngo wirinde kurakara, ni ngombwa guhinduranya ibibanza byatewe inshinge buri gihe. Ibi bifasha kugabanya ibyago byububabare bwaho, kubyimba, cyangwa gutukura bivuye inshinge nyinshi mukarere kamwe.
Abantu benshi bagaragaza ibimenyetso byoroheje gastrointestinal mugihe batangiye tirzepatide. Ibi birashobora kubamo isesemi, impiswi, kuribwa mu nda, kubyimba, cyangwa kuruka nkuko sisitemu y'ibiryo ihuza no gusohora gahoro gahoro. Izi ngaruka mubisanzwe nigihe gito kandi akenshi zitera imbere mubyumweru bike ukomeje gukoreshwa. Kurya amafunguro mato, kuguma ufite amazi, no kwirinda ibiryo birimo amavuta menshi mugihe cyo kuvura hakiri kare birashobora kugabanya ibibazo.
Abakoresha bamwe babona umutuku, guhinda, cyangwa kubyimba byoroheje aho batewe inshinge. Izi reaction ntabwo zangiza kandi mubisanzwe zirashira vuba. Guhinduranya inshinge - ikibero, inda, cyangwa ukuboko hejuru - bifasha kwirinda kurakara. Gukoresha uburyo bukwiye bwo gutera inshinge no kwemerera imiti kugera kubushyuhe bwicyumba mbere yo kuyikoresha nabyo bishobora kugabanya ibibazo.
Mubihe bidasanzwe, tirzepatide irashobora gukurura ibibazo bya gallbladder cyangwa pancreatitis. Ibimenyetso byo kuburira birimo ububabare butunguranye, bukabije bwigifu, ububabare bukwirakwira inyuma, kuruka guhoraho, umuriro, cyangwa jaundice (umuhondo wuruhu cyangwa amaso). Kubera ko pancreatite ishobora guhitana ubuzima, ububabare bwo munda ubwo ari bwo bwose cyangwa buhoraho bugomba gusuzumwa n’ubuvuzi.
Tirzepatid itanga umuburo werekeranye nibishobora guterwa na tiroyide C-selile. Nubwo bidasanzwe, abayikoresha bagomba gukurikirana ibimenyetso nkibibyimba mu ijosi, ikibazo cyo kumira, gutontoma, cyangwa guhumeka neza. Kimwe muri ibyo bimenyetso gisaba kwisuzumisha kwa muganga. Guhindura imitekerereze birashobora no kugaragara kubantu bumva. Ibyiyumvo byo kwiheba, guhangayika, cyangwa guhindura imyitwarire idasanzwe bigomba kumenyeshwa abashinzwe ubuzima bidatinze.
Abantu benshi bibaza niba kugabanuka ibiro biva kuri tirzepatide bimara nyuma yo guhagarika kwivuza. Ubuvuzi bwa Clinical bwerekana ko kugarura ibiro bisanzwe iyo imiti ihagaritswe. Mu igeragezwa rya SURMOUNT-4, abitabiriye bahagaritse tirzepatide bagaruye hafi 14% yuburemere bari baratakaje, kabone niyo byakurikiranwe buri gihe. Ibi bibaho kuko ingaruka zo kurya no guhagarika ingaruka za tirzepatide ntizigishyigikira kugabanuka kwa calorie igihe imiti ihagaze. Ibyavuye mu bushakashatsi byerekana ko tirzepatide ikora neza nkigice cyingamba zigihe kirekire zo kwita aho gukosorwa mugihe gito.
Umubyibuho ukabije ubu uzwi nk'indwara idakira, yisubiramo - nka hypertension cyangwa diyabete. Ibyo bivuze ko imiyoborere ihoraho ari ngombwa. Tirzepatid itanga ubufasha bwa metabolike ifasha abantu gukomeza inzara nkeya, kurwanya glucose neza, hamwe nuburyo bwiza bwo kurya. Iyo ikoreshejwe ubudahwema, irashobora guhagarika gucunga igihe kirekire kandi ikagabanya ibyago byo gusiganwa ku magare. Ku bantu benshi, tirzepatide iba imwe muri gahunda yuzuye yo kuvura umubyibuho ukabije aho kuba imiti yigihe gito.
Kugirango ugabanye ibiro, abarwayi akenshi bakeneye gukomeza tirzepatide irenze icyiciro cyambere cyo kuvura. Ubuvuzi bukomeje bufasha kubungabunga iterambere mu kurwanya ubushake bwo kurya no gukora metabolike. Abatanga ubuvuzi barashobora guhindura ibipimo cyangwa bagasaba ubuvuzi bwo murwego rwo kubungabunga bitewe niterambere ryabantu kugiti cyabo no kwihanganira ingaruka. Kwisuzumisha buri gihe kandi bifasha kwemeza ko ubuvuzi bukomeza kuba bwiza kandi butekanye mugihe runaka.
Imiti yonyine ntishobora kwemeza ibisubizo bihoraho. Kubungabunga ibiro biramba bisaba ingeso zubuzima. Indyo yuzuye hamwe nibice bishobora gucungwa, imyitozo ngororamubiri isanzwe, hamwe nisuku nziza yo gusinzira byose bigira uruhare runini mugushigikira intsinzi yigihe kirekire. Izi ngeso zifasha gushimangira iterambere ryagezweho hamwe na tirzepatide no koroshya inzibacyuho niba imiti igabanutse cyangwa igahagarikwa nyuma. Abantu bahuza tirzepatide na gahunda nziza birashoboka cyane ko bagabanya ibiro kandi bakirinda gusubirana vuba bigaragara mubushakashatsi bwubuvuzi.
Tirzepatid itanga inkunga ikomeye kubantu bafite umubyibuho ukabije cyangwa ibihe bijyanye nuburemere. Igabanya ubushake bwo kurya, ikongera ibyuzuye, kandi igafasha kugenzura isukari yamaraso kugirango igabanye ibiro neza. Gukoresha igihe kirekire ningeso nziza birashobora gukenerwa kugirango ukomeze ibisubizo. Cocer Peptides ™ itanga ibisubizo byiza bya tirzepatide byashizweho kugirango bishyigikire umusaruro mwiza hamwe nigihe kirekire cyo gucunga ibiro.
Igisubizo: Tirzepatid ni inshinge ya buri cyumweru ifasha kugabanya ubushake bwo kurya no gushyigikira kugabanya ibiro.
Igisubizo: Tirzepatid ikora mukongera ubwuzure no gutinda igogora, ifasha kugabanuka gahoro gahoro.
Igisubizo: Tirzepatid irashobora gufasha abantu bakuru bafite umubyibuho ukabije cyangwa ibihe bijyanye nuburemere kugera kuburemere bugaragara.
Igisubizo: Tirzepatid akenshi itera kugabanuka cyane ugereranije n'imiti isa.
Igisubizo: Ingaruka zoroheje zirashobora kubaho; vugana nuwaguhaye niba ibimenyetso bikomeje mugihe cyo kuvura tirzepatide.